Trump unveils deal with Regeneron to lower drug prices as part of most-favored-nation initiative
President Donald Trump on Thursday announced a deal with drugmaker Regeneron to lower the cost of its pharmaceutical…
SNY & REGN’s Dupixent Gets EU Nod for Chronic Spontaneous Urticaria
Sanofi SNY and partner Regeneron REGN announced that the European Commission has approved Dupixent (dupilumab) for the treatment of…
‘I cannot describe this feeling’
Adam Kovalčík didn’t expect to win big when he flew from his small village in Slovakia to an…